Insights on increasing the translational value of your preclinical development program.
Sep 15, 2025by MD Biosciences
MD Biosciences has signed the Marseille Declaration, the first joint pharmaceutical industry statement on animal...
Sep 11, 2025by MD Biosciences
We had the opportunity to present at NeuPSIG 2025 in Berlin, sharing our latest findings in neuropathic pain research....
Aug 20, 2025by MD Biosciences
Spinal cord injury (SCI) remains one of the most challenging neurological conditions to treat, with few therapies...
Jul 15, 2025by MD Biosciences
Bridging the gap between preclinical and clinical research remains one of the most pressing challenges in drug...
Jul 11, 2025by MD Biosciences
MD Biosciences presented at the European Wound Management Association 2025 in Barcelona. Dr. Avital Schauder showcased...
.png?width=400&height=400&name=Untitled%20design%20(3).png)
